The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Anlotinib combined with mXELIRI as second-line treatment in advanced colorectal cancer pretreated with bevacizumab plus standard chemotherapy: A single-arm, phase IB/II study.
 
Xin Qu
No Relationships to Disclose
 
Xian Chen
No Relationships to Disclose
 
Yong Li
No Relationships to Disclose
 
Li-rong Liu
No Relationships to Disclose
 
Yan-chun Qu
No Relationships to Disclose
 
Fang-fang Hou
No Relationships to Disclose
 
Wen-zhu Li
No Relationships to Disclose
 
Yi-hong Liu
No Relationships to Disclose
 
Yan-juan Zhu
No Relationships to Disclose
 
Haibo Zhang
No Relationships to Disclose